A previous study also showed that the dysfunction or downregulation of LTC4S, one of the key enzymes of the 5-lipoxygenase pathway, was associated with increased risk of venous thromboembolism and ischemic stroke (Freiberg et al., 2010). Here, LTC4S is linked to ischemic stroke.